Metabolic modeling of organ-specific doses to carcinogens as illustrated with alpha-radiation emitting radionuclides.
Quantitative estimation of doses of carcinogens delivered to physiologic targets facilities specification of organ-specific dose-response functions. Typically, exposure measurements, such as air or water concentrations of carcinogens, are used as dose surrogates in epidemiologic studies. An illustrative exception to this usual situation is the case of airborne alpha radiation-emitting radionuclides, for which organ-specific doses can be derived. A metabolic modeling approach for estimating doses delivered to the lung, gastrointestinal tract and bone is described for three classes of radionuclides: soluble uranium, insoluble uranium and plutonium. The dose models are defined in terms of biological retention patterns and organ-specific depositions affinities. Application of the metabolic modeling approach is illustrated with a hypothetical example of excess lung cancer risk projection in a cohort of persons exposed to plutonium. Also, a simple example is presented to demonstrate how adherence to the metabolic model structure can avoid gross overestimation of doses in the case of multiple in vivo lung counting measurements taken in close temporal proximity following a large exposure intake.
Checkoway
H
H
Department of Epidemiology, University of North Carolina, Chapel Hill 27514.
Crawford-Brown
D
D
D004307:Dose-Response Relationship, Radiation; D006207:Half-Life; D006801:Humans; D008175:Lung Neoplasms / Q000209:etiology; D008954:Models, Biological; D009381:Neoplasms, Radiation-Induced / Q000209:etiology* / Q000378:metabolism; D009784:Occupational Diseases / Q000209:etiology; D011005:Plutonium / Q000009:adverse effects; D011839:Radiation, Ionizing; D011868:Radioisotopes / Q000009:adverse effects*; D013997:Time Factors; D014501:Uranium / Q000009:adverse effects
D011868:Radioisotopes; D014501:Uranium; D011005:Plutonium